Sitemap

Sitemap

About Us (RedirectPage)
Newsroom (newsroom)
- 2013 (contentTopForLists)
  - Now Open Broad Agency Announcements (NewsroomArticles)
  - FFMN Solicitation No 13-100-SOL-0000 (NewsroomExternalLinks)
  - HHSAwardADDevelopmentNovelFlu (NewsroomExternalLinks)
  - PAHPA (NewsroomExternalLinks)
  - Smart DME-Power Generation RFI (NewsroomExternalLinks)
  - RFIAgentsTreatmentNewThreats (NewsroomExternalLinks)
  - FDAApprovBotulismAntitoxinHeptavalent (NewsroomExternalLinks)
  - Lurie_FDAApprovBotulismAntitoxinHeptavalent (NewsroomExternalLinks)
  - Clinical_Studies_Network_RFP (NewsroomExternalLinks)
  - TestIdentifyResistantFlu (NewsroomExternalLinks)
  - PresolicitationAncillaryInfluPreparedness (NewsroomExternalLinks)
  - StrategicAllianceDevAntibiotics (NewsroomExternalLinks)
  - BARDA Proposal Public Health and Medical Consequence Modeling Network (NewsroomExternalLinks)
  - BARDA Supports New Broad-Spectrum Antibiotic Drug (NewsroomExternalLinks)
  - Pre-Solicitation Notice for the Advanced Research and Development (NewsroomExternalLinks)
  - Pre-Solicitation Notice for Science and Technology Platforms (NewsroomExternalLinks)
  - Pre-Solicitation Notice for the Advancement of Medical Countermeasures (NewsroomExternalLinks)
  - HHSBAANewsRelease (NewsroomExternalLinks)
  - BAAPreProposalConference (NewsroomExternalLinks)
  - SmallMoleculeDev (NewsroomExternalLinks)
  - PBS_Report_2012 (NewsroomExternalLinks)
  - EvalSevereThermalBurns (NewsroomExternalLinks)
  - BARDA evaluates burn dressing for radiation, sulfur mustard burns (NewsroomExternalLinks)
  - BARDA funds study of therapy for thermal burns (NewsroomExternalLinks)
  - HHS replenishes nation’s supply of anthrax antitoxin (NewsroomExternalLinks)
  - HHS pursues nerve agent anti-seizure drug for children and adults (NewsroomArticles)
  - HHS boosts stockpile of products to treat acute radiation syndrome (NewsroomExternalLinks)
  - HHS boosts national capacity to produce pandemic flu vaccine (NewsroomExternalLinks)
  - HHSNewBloodAnthraxTest (NewsroomExternalLinks)
- 2014 (contentTopForLists)
  - Drug_Bioterrorism_Antimicrobial-resistant_Infections (NewsroomExternalLinks)
  - network to perform clinical studies (NewsroomExternalLinks)
  - Now Open Broad Agency Announcements (NewsroomArticles)
  - BID2014_RegistrationOpen (NewsroomExternalLinks)
  - CIADM_RTOR_Pfenex (NewsroomExternalLinks)
  - Establish Adjuvant Hub (NewsroomExternalLinks)
  - CIADM_RTOR_Vaxin (NewsroomExternalLinks)
  - EbolaFAQ (NewsroomExternalLinks)
  - MappEbolaDevelopment (NewsroomExternalLinks)
  - ProfectusEbolaVaccine (NewsroomExternalLinks)
  - BARDA Chem and RadNuc Animal Model Development (NewsroomExternalLinks)
  - develop next-generation portable ventilator (NewsroomExternalLinks)
  - severe infections and prevent cytokine storm (NewsroomExternalLinks)
  - detection tests for influenza (NewsroomExternalLinks)
  - speed Ebola vaccine delivery (NewsroomExternalLinks)
- 2021 (contentTopForLists)
  - RegeneronPurchase (NewsroomArticles)
  - Lillyincrease (NewsroomArticles)
  - VisbyMedical (NewsroomArticles)
  - COVID19purchases (NewsroomArticles)
  - Luminex (NewsroomArticles)
  - LightDeck (NewsroomArticles)
  - JanssenEUA (NewsroomArticles)
  - Hologic assay4 (NewsroomArticles)
  - Lilly (NewsroomArticles)
  - MerckJ&J (NewsroomArticles)
  - MediciNova (NewsroomArticles)
  - ContraFect (NewsroomArticles)
  - NCATS (NewsroomArticles)
  - DiaSorinSpA (NewsroomArticles)
  - FirstString (NewsroomArticles)
  - MaskChallenge (NewsroomArticles)
  - Janssen (NewsroomArticles)
  - ortho (NewsroomArticles)
  - ebolataskforce (NewsroomArticles)
  - AgileMD (NewsroomArticles)
  - PeraHealth (NewsroomArticles)
  - BAAAntibacterial (NewsroomArticles)
  - BID2021Save (NewsroomArticles)
  - Ventures (NewsroomArticles)
  - TEMBEXA (NewsroomArticles)
  - LIAISON (NewsroomArticles)
  - Merck (NewsroomArticles)
  - Dascena (NewsroomArticles)
  - StrataGraft (NewsroomArticles)
  - Moderna (NewsroomArticles)
  - ARP (NewsroomArticles)
  - LightningTalks (NewsroomArticles)
  - BioAegis (NewsroomArticles)
  - Paratek (NewsroomArticles)
  - LightningTalksOpen (NewsroomArticles)
  - LightDeckDiag (NewsroomArticles)
  - Cepheid (NewsroomArticles)
- 2020 (contentTopForLists)
  - Novel Coronavirus (NewsroomExternalLinks)
  - nCoV Market Research (NewsroomArticles)
  - Coronavirus Emergency (NewsroomExternalLinks)
  - AUDENZTM H5N1 (NewsroomExternalLinks)
  - Regeneron Therapeutic (NewsroomExternalLinks)
  - nCoV EZ BAA (NewsroomExternalLinks)
  - Janssen Coronavirus (NewsroomExternalLinks)
  - Sanofi nCoV (NewsroomExternalLinks)
  - Janssen nCoV (NewsroomExternalLinks)
  - COVID19 Diagnostic (NewsroomExternalLinks)
  - Hologic Diagnostic (NewsroomArticles)
  - COVID-19 Diagnostic Test (NewsroomExternalLinks)
  - Cepheid Diagnostic (NewsroomArticles)
  - Mesa Biotech COVID-19 (NewsroomArticles)
  - Qiagen COVID-19 (NewsroomArticles)
  - DiaSorin COVID-19 (NewsroomArticles)
  - Janessen COVID-19 various (NewsroomArticles)
  - Moderna COVID-19 mRNA (NewsroomArticles)
  - Janssen Vaccine COVID-19 (NewsroomArticles)
  - Cue SARS-CoV-2 (NewsroomArticles)
  - Nanomix Diagnostic (NewsroomArticles)
  - Luminex NxTag Diagnostic (NewsroomArticles)
  - SAB-185 (NewsroomArticles)
  - Grilfols Plasma (NewsroomArticles)
  - GenMark Diagnostic (NewsroomArticles)
  - Luminex Aries Diagnostic (NewsroomArticles)
  - Emergent Plasma (NewsroomArticles)
  - Genetech (NewsroomArticles)
  - Plasma Immunotherapies (NewsroomArticles)
  - SNS Donations (1) (NewsroomArticles)
  - OraSure Diagnostic (NewsroomArticles)
  - DiaSorin (NewsroomArticles)
  - Vela Diagnostic (NewsroomArticles)
  - ARC Donors (NewsroomArticles)
  - PSC Sanofi Recombinant (NewsroomArticles)
  - Hememics Diagnostic (NewsroomArticles)
  - Tangen Diagnostic (NewsroomArticles)
  - Cytovale Diagnostic (NewsroomArticles)
  - Inbios Diagnostic (NewsroomArticles)
  - Americas Blood Centers (NewsroomArticles)
  - Cerus INTERCEPT (NewsroomArticles)
  - Hologic Assay (NewsroomArticles)
  - Mayo Clinic (NewsroomArticles)
  - Beckman Coulter (NewsroomArticles)
  - Phlow US Manufacturing (NewsroomArticles)
  - VitalConnect (NewsroomArticles)
  - Philips Lumify (NewsroomArticles)
  - COVID Vaccine (NewsroomArticles)
  - Merck IAVI (NewsroomArticles)
  - Genentech Therapeutic (NewsroomArticles)
  - Emergent Manufacturing (NewsroomArticles)
  - Quidel Diagnostic (NewsroomArticles)
  - Siemens Healthineers (NewsroomArticles)
  - Evidaton Health wearable (NewsroomArticles)
  - Moderna vaccine (NewsroomArticles)
  - AstraZeneca (NewsroomArticles)
  - ChembioZikaFDA (NewsroomArticles)
  - SepsisAlliance (NewsroomArticles)
  - Snapdragon (NewsroomArticles)
  - OraSurevitro (NewsroomArticles)
  - FDA EUA End (NewsroomExternalLinks)
  - Regeneron study (NewsroomArticles)
  - Immunexpress (NewsroomArticles)
  - OrthoClinicalDiagnostics (NewsroomArticles)
  - Corning (NewsroomArticles)
  - Empatica (NewsroomArticles)
  - MBio (NewsroomArticles)
  - CSU (NewsroomArticles)
  - Sonica (NewsroomArticles)
  - BID (NewsroomArticles)
  - Chembio DPP (NewsroomArticles)
  - SiO2 (NewsroomArticles)
  - NovavaxHHSDOD (NewsroomArticles)
  - RegeneronHHSDOD (NewsroomArticles)
  - LightningTalks2020 (NewsroomArticles)
  - RTI (NewsroomArticles)
  - BD (NewsroomArticles)
  - Smiths (NewsroomArticles)
  - Pfizer (NewsroomArticles)
  - TAMUS (NewsroomArticles)
  - LightningTalksApply (NewsroomArticles)
  - Moderna-Phase-3 (NewsroomArticles)
  - Sanofi_GSK (NewsroomArticles)
  - JanssenRapidARD (NewsroomArticles)
  - GrandRiver (NewsroomArticles)
  - Diasorin-Antibody-Test (NewsroomArticles)
  - ModernaManufacturing (NewsroomArticles)
  - BARDA-New-Partnerships (NewsroomArticles)
  - NOWDiagnostics (NewsroomArticles)
  - Marinus (NewsroomArticles)
  - 98point6 (NewsroomArticles)
  - OlogyBio (NewsroomArticles)
  - Ortho (NewsroomArticles)
  - UPenn (NewsroomArticles)
  - Luminex (NewsroomArticles)
  - LuminexNxTAG (NewsroomArticles)
  - Basilea (NewsroomArticles)
  - Invirsa (NewsroomArticles)
  - antibioticresistant (NewsroomArticles)
  - Mapp (NewsroomArticles)
  - BARDAMsg (NewsroomArticles)
  - Vaxxas (NewsroomArticles)
  - CurrentHealth (NewsroomArticles)
  - Cepheid (NewsroomArticles)
  - AstraZeneca2 (NewsroomArticles)
  - Cytiva (NewsroomArticles)
  - BeckmanCoulter (NewsroomArticles)
  - TRI (NewsroomArticles)
  - CSN (NewsroomArticles)
  - EZ-BAA (NewsroomArticles)
  - Lilly (NewsroomArticles)
  - InBios2 (NewsroomArticles)
  - Hologic (NewsroomArticles)
  - Humanigen (NewsroomArticles)
  - MesaBiotech (NewsroomArticles)
  - Ventures (NewsroomArticles)
  - BID2020Message (NewsroomArticles)
  - DiaSorinIgG (NewsroomArticles)
  - Siemens (NewsroomArticles)
  - SiemensCoV2Ag (NewsroomArticles)
  - Chrysalis (NewsroomArticles)
  - ENACT (NewsroomArticles)
  - Lilly2 (NewsroomArticles)
  - Chembio (NewsroomArticles)
  - GHTC (NewsroomArticles)
  - Moderna (NewsroomArticles)
  - QuantumLeap (NewsroomArticles)
  - Hologicassay (NewsroomArticles)
  - ModernaEUA (NewsroomArticles)
  - Ridgeback (NewsroomArticles)
  - Merck (1) (NewsroomArticles)
  - Pfizer (1) (NewsroomArticles)
  - Eoy2020 (NewsroomArticles)
  - Challenge (NewsroomArticles)
  - DiaSorinSimplexacombo (NewsroomArticles)
- 2015 (contentTopForLists)
  - 2014 PHEMCE SIP (NewsroomExternalLinks)
  - CRO Nonclinical Studies SB (NewsroomExternalLinks)
  - CRO Nonclinical Studies Other (NewsroomExternalLinks)
  - Universal Flu Vaccine RFP (NewsroomExternalLinks)
  - AnthraxVaccine (NewsroomExternalLinks)
  - Animal Model Development RFP (NewsroomExternalLinks)
  - Continuous Manufacturing RFI (NewsroomExternalLinks)
  - AD BS Influenza Monoclonal Antibodies (NewsroomExternalLinks)
  - Emergent CIADM Ebola (NewsroomExternalLinks)
  - RFP for Advanced Development of Broad-Spectrum Influenza Monoclonal Antibodies (NewsroomExternalLinks)
  - DevAnthraxVaccine (NewsroomExternalLinks)
  - ExperimentalEbolaVaccine (NewsroomExternalLinks)
  - AllianceAntibioticDevelopment (NewsroomExternalLinks)
  - DevelopmentMonoclonalAntibodyEbola (NewsroomExternalLinks)
  - DisasterUseApprovedClotBusting (NewsroomExternalLinks)
  - DevelopmentHospitalizedInfluenzaPatients (NewsroomExternalLinks)
  - Novel drug to treat influenza (NewsroomExternalLinks)
  - NewProductSevereBurns (NewsroomExternalLinks)
  - ImproveInfluenzaVaccines (NewsroomExternalLinks)
  - PresolicitationBAAFlu (NewsroomExternalLinks)
  - Broad Agency Announcements (NewsroomArticles)
  - Coming Soon: Broad Agency Announcements (NewsroomExternalLinks)
  - New Skin Substitute (NewsroomExternalLinks)
  - Inhalational anthrax treatments (NewsroomExternalLinks)
  - Draft RFP Respiratory Illness Live Virus Fill / Finish Services (NewsroomExternalLinks)
  - SSN Respiratory Illness Live Virus Fill / Finish Services (NewsroomExternalLinks)
  - Manufacturing N95 Respirators (NewsroomExternalLinks)
- 2016 (contentTopForLists)
  - Pre-Solicitation Biological Animal Model Development (NewsroomExternalLinks)
  - AntimicrobialResistancePartner (NewsroomExternalLinks)
  - Zika Blood Product (NewsroomExternalLinks)
  - New BSA Development (NewsroomExternalLinks)
  - Zika Diagnostics (NewsroomExternalLinks)
  - Decontamination Study (NewsroomExternalLinks)
  - Anthrax Diagnostic Test (NewsroomExternalLinks)
  - Nasal Anthrax Vaccine (NewsroomExternalLinks)
  - Pathogen Reduction Technologies (NewsroomExternalLinks)
  - CIADM Zika Vaccine (NewsroomExternalLinks)
  - Zika Vaccine Capacity Brazil (NewsroomExternalLinks)
  - Regional Ebola Treatment Center (NewsroomExternalLinks)
  - CARB-X (NewsroomExternalLinks)
  - Zika Diagnostic (NewsroomExternalLinks)
  - Single Dose Anthrax (NewsroomExternalLinks)
  - Zika Emergency Puerto Rico (NewsroomExternalLinks)
  - DiaSorin Zika (NewsroomExternalLinks)
  - OraSure Zika (NewsroomExternalLinks)
  - Chembio Zika (NewsroomExternalLinks)
  - Takeda Zika (NewsroomExternalLinks)
  - Moderna Zika (NewsroomExternalLinks)
  - AMR Prize (NewsroomExternalLinks)
  - New Antibiotics (NewsroomExternalLinks)
  - Zika Vaccine Sanofi (NewsroomExternalLinks)
  - Bioterrorism Antidote (NewsroomExternalLinks)
  - Genetic Sequencing Platform (NewsroomExternalLinks)
  - Next Gen Anthrax (NewsroomExternalLinks)
  - Tests ebola vaccine (NewsroomExternalLinks)
  - Test Radiation Absorbed (NewsroomExternalLinks)
  - Radiological Threats (NewsroomExternalLinks)
  - New BARDA Director (NewsroomExternalLinks)
- 2017 (contentTopForLists)
  - CARB-X Competition (NewsroomExternalLinks)
  - CARB-X Drug Discovery and Dev (NewsroomExternalLinks)
  - Zika Diagnostic (NewsroomExternalLinks)
  - High-Throughput Biodosimetry (NewsroomExternalLinks)
  - Point of Care Biodosimetry Tests (NewsroomExternalLinks)
  - RFP Biodosimetry POC (NewsroomExternalLinks)
  - RFP Biodosimetry High Throughput (NewsroomExternalLinks)
  - CARB-X Announces Funding for Global Scientists (NewsroomExternalLinks)
  - New Antibiotic (NewsroomExternalLinks)
  - Antibiotic Ridinilazole (NewsroomExternalLinks)
  - Janssen Influenza (NewsroomExternalLinks)
  - Cyanide Intranasal (NewsroomExternalLinks)
  - Anthrax POC Test (NewsroomExternalLinks)
  - Respiratory Drug Chemical Antidote (NewsroomExternalLinks)
  - Smallpox Vaccine Special Pop (NewsroomExternalLinks)
  - Ebola Vaccines (NewsroomExternalLinks)
  - Reusable Respirator (NewsroomExternalLinks)
  - Influenza and EID (NewsroomExternalLinks)
  - Radiation Exposure Tests (NewsroomExternalLinks)
  - Infection Antibiotic (NewsroomExternalLinks)
  - Radiation Blood Platelets (NewsroomExternalLinks)
  - CARB-X Amicidin-β (NewsroomExternalLinks)
  - 2018 BAA (NewsroomExternalLinks)
  - Anthrax Diagnostic (NewsroomExternalLinks)
- 2018 (contentTopForLists)
  - Leukine ARS (NewsroomExternalLinks)
  - ENACT and Sepsis (NewsroomArticles)
  - Decontamination (NewsroomExternalLinks)
  - DRIVe Funding (NewsroomExternalLinks)
  - Antrhrax SNS Purchase (NewsroomExternalLinks)
  - Nerve Agent (NewsroomExternalLinks)
  - Philadelphia Accelerator (NewsroomExternalLinks)
  - Houston Accelerator (NewsroomExternalLinks)
  - New York Accelerator (NewsroomExternalLinks)
  - New Orleans Accelerator (NewsroomExternalLinks)
  - Los Angeles Accelerator (NewsroomExternalLinks)
  - Greater Boston Accelerator (NewsroomExternalLinks)
  - Raleigh-Durham Accelerator (NewsroomExternalLinks)
  - Seattle-Bellevue Accelerator (NewsroomExternalLinks)
  - BID2018 (NewsroomArticles)
  - TPOXX (NewsroomExternalLinks)
  - Novel (NewsroomExternalLinks)
  - Lightning Talk Applications (NewsroomArticles)
  - flu test (NewsroomExternalLinks)
  - Sulfur Mustard (NewsroomExternalLinks)
  - Faster Tests (NewsroomExternalLinks)
  - Smallpox Antiviral (NewsroomExternalLinks)
  - Genentech (NewsroomExternalLinks)
  - Burn Dressing (NewsroomExternalLinks)
  - Security Threats (NewsroomExternalLinks)
- 2019 (contentTopForLists)
  - Expand Accelerators (NewsroomExternalLinks)
  - Marburg (NewsroomExternalLinks)
  - BurnDeepView (NewsroomExternalLinks)
  - VenatoRx (NewsroomExternalLinks)
  - SilverlonSulferMustard (NewsroomExternalLinks)
  - Lightning Talk Applications 2019 (NewsroomArticles)
  - Smallpox Vaccine Purchase SNS (NewsroomExternalLinks)
  - Expand Accelerator Network (NewsroomExternalLinks)
  - Investigational Ebola Treatment (NewsroomExternalLinks)
  - Smallpox and Monkeypox Licensed Vaccine (NewsroomExternalLinks)
  - Blood Platelets (NewsroomExternalLinks)
  - Filovirus Vaccines (NewsroomExternalLinks)
  - Lung Chip (NewsroomExternalLinks)
  - Lightning Talks Selectees (NewsroomArticles)
  - ebola RDT (NewsroomExternalLinks)
  - Sepsis Algorithm (NewsroomExternalLinks)
  - Cytovale Sepsis (NewsroomExternalLinks)
  - Bacterial from Viral (NewsroomExternalLinks)
  - Modernize Influenza (NewsroomExternalLinks)
  - Anthrax Lung Infections (NewsroomExternalLinks)
  - Ebola Vaccine (NewsroomExternalLinks)
- Archive (Content)
- Enalare (NewsroomArticles)
- Enalare (RedirectPage)
Federal Initiatives (FederalInitiatives)
- Public Meetings (contentFed)
  - BARDA Industry Day 2019 (conference)
    - Hotel Accommodations (Content)
    - Directions (Content)
    - About BARDA Industry Day (Content)
    - FAQ (Content)
    - Hybrid Events (Content)
    - Speakers (Content)
    - presentations (Content)
  - BARDA Industry Day 2017 (conference)
    - Presentations (Content)
    - About BARDA BID (Content)
    - Hotel Accommodations (Content)
    - Keynote Speaker (Content)
  - BARDA Industry Day 2016 (conference)
    - Why Attend (Content)
    - Meeting Opportunities (Content)
    - Hotel Accommodations (Content)
    - Breakout Session Opportunities (Content)
    - Presentations (Content)
  - BARDA Industry Day 2018 (conference)
    - Hotel Accommodations (Content)
    - Directions (Content)
    - About BARDA Industry Day (Content)
    - Presentations (Content)
    - Keynote Speaker (Content)
    - Lightning Talks (Content)
  - HHS Summit to Accelerate Zika Diagnostics Development (conference)
  - JPM-MCS Industry Day : Proposed Other Transaction Agreement (conference)
  - BARDA Industry Day 2015 (conference)
    - Why Attend (Content)
    - Meeting Opportunities (Content)
    - Hotel Accommodations (Content)
    - Presentations (Content)
  - WorkshopBID2014 (conference)
    - Workshop2014WhyAttend (Content)
    - Workshop2014MeetingOpportunity (Content)
    - hotels (Content)
    - Presentations - BARDA Industry Day 2014 (Content)
  - WorkshopBID2013 (conference)
    - Workshop2013WhyAttend (Content)
    - Workshop2013MeetingOpportunity (Content)
    - hotels (Content)
    - Presentations - BARDA Industry Day 2013 (Content)
  - BAAPreProposalConference2013 (conference)
  - WorkshopBID2012 (conference)
    - Workshop2012MeetingOpportunity (Content)
    - Workshop2012WhoAttends (Content)
    - Workshop2012Register (Content)
    - Workshop2012WhyAttend (Content)
    - Presentations (Content)
    - Announcement1026 (Content)
    - Announcement1028 (Content)
  - PreProposalConference2012 (conference)
    - guidlines (Content)
  - BloodSymposium (conference)
  - WorkshopBoston (conference)
    - Presentations (Content)
    - WorkshopBostonWhoAttends (Content)
    - WorkshopBostonMeetingOpportunity (Content)
    - WorkshopBostonRegister (Content)
  - PHEMCE Stakeholders Workshop 2016 (conferenceLink)
  - 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day (conferenceLink)
  - HHS PHEMCE Stakeholders Workshop 2009 and BARDA Industry Day (conferenceLink)
  - CBRN Medical Countermeasures Workshop (conferenceLink)
  - HHS PHEMCE Stakeholders Workshop 2008 and BARDA Industry Day (conferenceLink)
  - 2007 Biomedical Advanced Research and Development Authority (BARDA) Industry Day (conferenceLink)
  - HHS PHEMC Enterprise Stakeholders Workshop (conferenceLink)
  - BioShield Stakeholders Workshop (conferenceLink)
  - BARDA Industry Day 2020 (conferenceLink)
  - BARDA Vaccines Against AMR Threats Workshop (conferenceLink)
  - BID2021 (conferenceLink)
- Procurements and Grants (contentFed)
  - Federal Government Procurement Activities (contentFedItem)
  - Grants (contentFedItem)
  - Department and Agency Resources (contentFedItem)
  - Acquisition Regulations (contentFedItem)
  - Other Procurements and Grants Resources (contentFedItem)
- Strategies and Reports (contentFed)
  - Strategies and Reports (contentFedItem)
  - Public Health Emergency Medical Countermeasures Enterprise (contentFedItem)
  - NIH Strategic Planning (contentFedItem)
  - Pandemic Influenza (contentFedItem)
  - CBRN and Medical Countermeasure Reports (contentFedItem)
  - External Resources (contentFedItem)
- Guidance (contentFed)
  - Emergency Preparedness and Response (contentFedItem)
  - Drugs (contentFedItem)
  - Vaccines Blood and Biologics (contentFedItem)
  - Devices (contentFedItem)
  - Select Agent Rule (contentFedItem)
  - Animal Rule (contentFedItem)
  - Good Laboratory Practices (contentFedItem)
  - Technology Readiness Levels (contentFedItem)
  - Guidance Regarding Specific Types of Medical Countermeasures (contentFedItem)
  - Acquisition Regulations (contentFedItem)
- Resources (contentFed)
  - Microbiology (contentFedItem)
  - Immunology and Testing (contentFedItem)
  - Genomics (contentFedItem)
Request BARDA TechWatch Meeting (uSGCoronaWatch)
NewsroomRSS (Content)
PhemceRSS (Content)
PhemceNewsroom (Content)
AnnouncementsArchive (Content)
PHEMCE (pHEMCE)
- PHEMCE Strategy and Implementation (Content)
- Requirements Setting (GenericWithSideBar)
  - HHS PHEMCE Strategy (Content)
- NIH (pHEMCESubPage)
- CDC (GenericSingleColWithSideBar)
- DHS (GenericSingleColWithSideBar)
- FDA (GenericSingleColWithSideBar)
- DOD (GenericSingleColWithSideBar)
- ASPR (GenericSingleColWithSideBar)
ProjectMaps (ContentTop)
- Domestic (Content)
- International (Content)
- Who (Content)
- Summary (Content)
Conference Survey (Content)
prism (RedirectPage)
2017 Conference Survey (Content)
Sitemap (Content)
Lightning Talks (Content)
XmlSitemap (xmlSiteMap)
Home5 (Content)
BARDA (bardaNew)
- CBRN (cBRNNew)
  - Project BioShield Overview (GenericSingleColWithSideBar)
    - Project BioShield Annual Report (Content)
    - Project BioShield Funding (Content)
  - 2009CBRNWorkshop (Content)
    - 2009CBRNVideo1 (Content)
    - 2009CBRNVideo2 (Content)
  - PRISM (GenericSingleColWithSideBar)
  - decontamination guidance for chemical incidents (RedirectPage)
  - Botulinum Toxin (Content)
  - Chemical Medical Countermeasures (Content)
  - Radiological and Nuclear Countermeasures (Content)
    - Radiation Exposure (Content)
  - CBRN Funding Activities (RedirectPage)
  - Broad Spectrum Antimicrobials (Content)
  - Diagnostics and Biodosimetry (Content)
    - Biothreat Diagnostics Program (Subcontentwithtab)
    - Biodosimetry Program (Subcontentwithtab)
  - Thermal Burn (Content)
  - Ebola (Content)
    - Ebola Therapeutics Program (Subcontentwithtab)
    - Ebola Vaccines Program (Subcontentwithtab)
  - Smallpox (Content)
  - MDRVaccines (aMR)
- Core Services (coreServicesNew)
  - Strategic Investor (RedirectPage)
  - Medical Countermeasures for Smallpox (Content)
  - Radiological and Nuclear Threats (Content)
  - CBRN Diagnostics and Biodosimetry (Content)
  - Regulatory and Quality Affairs (RedirectPage)
  - Animal Studies Program (RedirectPage)
  - Clinical Studies Support (RedirectPage)
  - CIADM (RedirectPage)
    - CIADMGovernance (RedirectPage)
  - Fill Finish Manufacturing Network (RedirectPage)
  - Modeling Hub (RedirectPage)
- Stockpile Building (GenericSingleColWithSideBar)
  - Project BioShield Annual Report (Content)
  - Project BioShield Funding (Content)
- Advancing Innovation (innovationNew)
  - BARDA Sepsis Awareness Month (sepsis)
  - TechWatch (RedirectPage)
- Popular Resources (GenericSingleColWithSideBar)
- Influenza And Emerging Infectious Diseases (GenericSingleColWithSideBar)
  - Pandemic Influenza Preparedness Spending Reports (Content)
  - Influenza Vaccine Development Programs (Content)
  - Pandemic Influenza Vaccine Stockpile Program (Content)
  - Influenza Diagnostics Program (Content)
  - Influenza Therapeutics Program (Content)
  - Influenza Vaccine Manufacturing Infrastructure (Content)
  - International Influenza Vaccine Manufacturing Capacity Building Program (Content)
  - Coronavirus (GenericSingleColWithSideBar)
    - Pharmaceutical Manufacturing in America (manufacturing)
- PHEMCE Management (GenericWithSideBar)
  - HHS PHEMCE Strategy And Implementation (Content)
  - 2008 PHEMCE Stakeholders Workshop (Content)
  - 2010 PHEMCE Stateholders Workshop (Content)
    - 2010SWBeakoutSessions (Content)
    - 2010SWPresentations (Content)
    - 2010SWWhoAttends (Content)
    - 2010SWHotList (Content)
    - 2010SWContactUs (Content)
  - 2009 PHEMCE Stakeholders Workshop (Content)
    - 2009SWBreakoutSessions (Content)
    - 2009SWPresentations (Content)
    - 2009SWWhoAttends (Content)
    - 2009SWContactUs (Content)
  - 2007 BARDA Day (Content)
  - 2007 PHEMCE Stakeholders Workshop (Content)
  - 2006 BioShield Stakeholders Workshop (Content)
    - 2006 BioShield Agenda (Content)
- Requirements Setting (GenericWithSideBar)
  - HHS PHEMCE Strategy (Content)
- Emerging Infectious Diseases (GenericSingleColWithSideBar)
  - Zika (Content)
  - Ebola (Content)
- test page (Content)
- BARDA COVID-19 Response (covid19New)
- WhoWeAre (whoWeAreNew)
- BARDA Industry Day 2020 (bid)
  - LT Selectees (bIDStdSubpageNew)
  - Bid Presentations (bIDStdSubpageNew1)
- BARDA BAA (bAANew)
- FAQ 2020 (fAQNew)
- Series (seriesNew)
  - QIAGEN LLC (seriesItem2020)
  - Cytovale Inc. (seriesItem2020)
  - Nanomix Inc. (seriesItem2020)
  - Cue Inc. (seriesItem2020)
  - GenMark Diagnostics, Inc. (seriesItem2020)
  - Emergent BioSolutions (seriesItem2020)
  - Ortho Clinical Diagnostics (seriesItem2020)
  - Empatica Inc. (seriesItem2020)
  - Mesa Biotech Inc. (seriesItem2020)
  - Grifols (seriesItem2020)
  - Cerus (seriesItem2020)
  - Immunexpress Inc. (seriesItem2020)
  - Janssen Research & Development, LLC (seriesItem2020)
  - Luminex Corporation (seriesItem2020)
  - Retractable Technologies, Inc. (seriesItem2020)
  - OraSure Technologies, Inc. (seriesItem2020)
  - SiO2 Materials Science (seriesItem2020)
  - MBio Diagnostics (seriesItem2020)
  - Tangen Biosciences, Inc. (seriesItem2020)
  - Colorado State University (seriesItem2020)
  - InBios (seriesItem2020)
  - Smiths Medical (seriesItem2020)
  - Corning Incorporated (seriesItem2020)
  - Grand River Aseptic Manufacturing, Inc. (seriesItem2020)
  - SAb Biotherapeutics (seriesItem2020)
  - Chembio (seriesItem2020)
  - Making Countermeasures (seriesVideoItem2020)
  - ImpactBurnCare (seriesItem2020)
  - Numerous (seriesItem2020)
- Be A Responder (joinTheFightNew)
- FDAapprovals (fDANew)
- Research (bardaResearchNew)
  - Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) (bardaResearchItemNew)
  - Development of a clinical assay to measure chlorinated tyrosine (bardaResearchItemNew)
  - Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012–2018 (bardaResearchItemNew)
  - Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012–2018 (bardaResearchItemNew)
  - Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012–2018 (bardaResearchItemNew)
  - Evaluation of BioThrax® and AV7909 Anthrax Vaccines in Adults 66 Years of Age or Older (bardaResearchItemNew)
  - Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus (bardaResearchItemNew)
  - Current State of Anthrax Vaccines and Key R&D Gaps Moving Forward (bardaResearchItemNew)
- Working at BARDA (workingAtBARDA)
- BARDA Industry Day 2021 (bID2021)
Video Library (videoLibrary)
- CBRNDirectorBID2020 (videoLibraryVideo)
- BARDACOVIDResponse (videoLibraryVideo)
- COVID19_MCM Investments (videoLibraryVideo)
- MakingCountermeasuresSeries (videoLibraryVideo)
- DirectorEUA (videoLibraryVideo)
- DRIVEProgram (videoLibraryVideo)
- AMR Workshop (videoLibraryVideo)
- CARBXPartnership (videoLibraryVideo)
- BioTalkCatalyst (videoLibraryVideo)
- COVIDVaccineHesitancy (videoLibraryVideo)
- ASKBARDA_CTPaused (videoLibraryVideo)
- ASKBARDA_CTSafety (videoLibraryVideo)
- ASKBARDA_CTPlanned (videoLibraryVideo)
- ASKBARDA_CTPlacebo (videoLibraryVideo)
- ASKBARDA_CTDSMB (videoLibraryVideo)
- ASKBARDA_CTOutcome (videoLibraryVideo)
- PublicPrivatePartnerships (videoLibraryVideo)
- PBS_BuildMCM (videoLibraryVideo)
- CARBXDRIVE (videoLibraryVideo)
- DRIVeInnovation (videoLibraryVideo)
- BeyondLab (videoLibraryVideo)
- BID2020 (videoLibraryVideo)
- Ventures Disbrow June2021 (videoLibraryVideo)
- Ventures Patel June2021 (1) (videoLibraryVideo)
- Ventures Yang June2021 (videoLibraryVideo)
Blogs (blogs)
- BARDAVentures (blog)
- InnovationChallenge (blog)
- Antibiotic Partnerships (blog)
- Ebola Efforts Continue (blog)
- Strong partnerships next generation antibiotics (blog)
- Flu Drug Earns FDA Approval (blog)
- Reflections on antibiotic resistance (blog)
- Crash Course (blog)
- Zika receives FDA Clearance (blog)
- Evolving Federal National Health Security (blog)
- 50 Million Diagnostic Tests Shipped (blog)
- Clinical Synergies (blog)
- Sepsis Solutions Help Covid Patients (blog)
- Critical Time For Public Service (blog)
- Raising Awareness (blog)
- BARDA Leverages Strong Partnerships (blog)
- Sepsis Skyrocketing (blog)
- Vaccine Uses Next Gen Technology (blog)
- Need for Speed (blog)
- Threat In My Backyard (blog)
- Power of Partnerships (blog)
- Close Encounter (blog)
- Crossing The Finish Line (blog)
- Novel Partnerships (blog)
- Building Better Pipeline of Products (blog)
- Leveraging Project BioShield (blog)
- Strengthening Antibiotics Pipeline (blog)
- Ebola Therapeutic (blog)
- Business Models to Enhance Antibiotic Development (blog)
- BSA Program (blog)
- Responding to the Threat (blog)
- Antibiotic Resistance and Why a Problem (blog)
- Changing Pandemic Influenza Vaccine Manufacturing (blog)
- Build and Sustain Robust MCM Pipeline (blog)
- Award Winning Pan Flu Preparedness (blog)
- Plan to Keep the Nation Safe (blog)
- Can Rapid, Near-Patient Flu Tests Improve Preparedness and Response (blog)
- BioShield (blog)
- Pandemic Influenza (blog)
- FDA Anti Seizure (blog)
- BARDA Partners (blog)
- New Smallpox (blog)
- 1918 to 2018 (blog)
- Decontamination Decoded (blog)
- BARDA Supports a Rapid Deployable (blog)
- BARDA Adds New Antibiotic (blog)
- New Frontiers and Extreme Environments (blog)
- Powering The Next Gen (blog)
- Next Generation Burn Care (blog)
- Better Preparing (blog)
- Anticipating Threats (blog)
- PHEMCE-Supported Drug Achieves FDA Approval (blog)
- Would Old Vaccine Work (blog)
- BARDA Seeks to Launch a Novel Partnership (blog)
- Better Protecting (blog)
- Bird Flu (blog)
- Fighting Antibiotic Resistance (blog)
- BARDA-Supported Zika Vaccine Candidate (blog)
- AMR (blog)
Stories (stories)
- Ebola Story (story)
- MaskChallenge (story)
- RQA_SME (story)

Website Refresh - www.medicalcountermeasures.gov is pleased to announce a phased launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience. Over the next several months you will see differences throughout the site while we continue implementing updates. Thank you for your understanding and please let us know if you have any questions: techwatchinbox@hhs.gov